Meanwhile, it can reduce tumor interstitial fluid pressure, increase drug penetration in tumors, and avoid hypoxia-induced immune escape.16, 17 Gao et al.20found that anlotinib-treated lung cancer mouse models showed reduced HIF-1α expression. This evidence concerns the gene HIF1A and neoplasm.